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Paraoxonase/arylesterases (EC.3.1.8.2) is an enzyme found tightly associated with high density 
lipoprotein particle in serum. Because of its unique enzyme activity, antioxidant property and its role as 
an anti atherosclerotic molecule, various methods are used for its purification from human serum. 
Methods involved in its purification are elaborate and complicated. Also the yield and final activity are 
highly variable. Here, we report a 2 step method of purification involving affinity chromatography on 
cibacron blue sepharose followed by gel filtration on sephadex G50.The final preparation was 27.7 fold 
purified compared with the serum and gave a single band in SDS-PAGE by silver staining.  
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INTRODUCTION  
 
Paraoxonase (E.C. 3.1.8.2), (PON) is an enzyme ubi-
quitously distributed in nature (La Du et al., 1992). In 
animals it is mainly found in blood in association with high 
density lipoprotein (HDL) particle, by a strong hydro-
phobic association through the N-terminal hydrophobic 
peptide (Kuo and La Du, 1995). Consequently methods 
of purification have employed isolation of HDL, dissocia-
tion of HDL-PON and subsequent purification of PON.  
PON was first purified by Main (1968). This method 
involved a series of ethanol precipitation and ammonium 
sulphate fractionation steps. The purified enzyme had a 
molecular weight ranging from 35 - 50 KDa.  
The other methods of purification involved precipitation 
of HDL using heavy metal salts (Burstein et al., 1970) or 
by density gradient centrifugation to separate HDL frac-
tion. More recent methods employ gel filtration of HDL on 
sepharose or affinity purification of HDL by affinity mate-
rial like cibacron blue sepharose or heparin-agarose 
(Chapman et al., 1971) .These methods also use other 
additional steps of purification. 
We report a 2 step method using affinity purification on 
cibacron blue sepahrose followed by gel filtration on 
sephadex G-50. 
 
 
MATERIALS AND METHODS  
 
Materials 
 
Glycine,  tris   buffer,   ammonium   per   sulphate,   acrylamide,  bis 
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acrylamide, coomassi brilliant blue, TEMED, SDS and ethylene 
diaminetetraaceticacid (EDTA) were purchased from SRL chemi-
cals (Mumbai, India). Cibacron blue 3GA and deoxycholate were 
purchased from Sigma Aldrich company USA. Acetic acid was pur-
chased from Ranbaxy chemicals (New Delhi). All other chemicals, 
acids, bases, solvents and salts used for the purification were of 
analytical grade. Dialysis bags used during dialysis was purchased 
from Thermo scientific life science research products, Rockford, 
USA. 
Human blood was collected from normal healthy volunteers 
according to guidelines mentioned by the institutional ethical com-
mittee for biomedical research. 
 
 
Methods  
 
Purification of human serum PON on affinity chromatography  
 
Human serum paraoxonase was purified by nonspecific affinity 
chromatography on cibacron blue 3GA. Cibacron blue sepharose 
(30 ml) was washed and suspended in column buffer which 
contained 10 mM tris-HCl, 1 mM CaCl2 and the pH was adjusted to 
8.2 (Kuo and La Du, 1995). The ratio of gel to serum was 
maintained 4:5 (v/v). Serum (45 ml) was mixed with an equal 
volume of column buffer and the mixture was loaded on cibacron 
blue gel column, (40 × 2 cm). The eluate was recycled through the 
column twice. The eluate was then collected in one fraction. The 
column was then washed with 30 ml of 4 M NaCl solution. The 4 M 
NaCl salt solution greatly reduces albumin or other soluble proteins 
from binding to cibacron blue gel and thus most of the soluble 
proteins and other lipoproteins are washed out of column. The salt 
fraction was collected in a separate tube to check whether it 
contained the esterase activity (Rodrigo et al., 1997). 
The column was then eluted with 30 ml of 0.1% deoxycholate 
and fractions were collected (1 ml). Optical density of the eluted 
fractions was measured at 280 nm. PON activity in the eluted frac-
tions was monitored by assaying the aryl esterase activity. The 
fractions containing PON were pooled separately. The pooled  frac- 
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tions were concentrated and further purified by gel filtration on 
sephadex G-50 column. 
 
 
Gel filtration on G- 50  
 
The pooled deoxycholate fraction (containing the aryl esterase 
enzyme activity) was loaded on sephadex G-50 column (50 × 2 cm) 
pre-equilibrated with 0.5 M NaCl solution. The column was also 
eluted with 0.5 M NaCl. 20 fractions (1 ml) were collected and the 
optical density was measured at 280 nm (Cordle et al., 1985).  
 
 
Dialysis 
 
The diluted protein fractions from G-50 with esterase activity were 
pooled (about 10 ml) and kept for dialysis in a dialysis bag with 8 
KDa cut-off. Dialysis was carried out overnight against double 
distilled water with 2 changes. This process facilitates removal of 
deoxycholate which was used during the elution of HDL fraction 
from affinity column and the salt from gel filtration column. Long 
time association of deoxycholate with paraoxonase affects its acti-
vity as well as its half life. 
 
 
Protein estimation by Lowry’s method  
 
Protein estimation was carried out according to Lowry’s method 
(Lowry, 1951) to estimate serum protein as well as protein in puri-
fied fractions.  
 
 
Assay of enzyme activity  
 
Synthesis of phenyl acetate 
 
10 ml of distilled phenol was taken in a round bottom flask and 20 
ml acetyl chloride was added and refluxed at 70°C for 1 h. The 
contents of the flask were cooled and 200 ml of ice cold water was 
added. Free acid was neutralized by adding calculated amount of 
NaOH. The oily layer was separated by dissolving it in petroleum 
ether. Petroleum ether layer was evaporated to yield Phenyl 
acetate (Gan et al., 1991). 
 
 
Aryl estrase activity 
 
PON 1 activity towards phenyl acetate was measured spectro-
photometrically at 270 nm in an automated shimadzu UV-1601, UV 
visible spectrophotometer. Buffer substrate was prepared by 
adding 50 mM Tris-HCl buffer pH 8.0 containing 2 mM Calcium. 
Phenyl acetate in Isopropyl alcohol was added such that the 
Phenyl acetate concentration was 2 mM and the isopropyl alcohol 
concentration was less than one percent. To 2.99 ml of buffered 
substrate 10 µl of the sample from different fractions was added 
and the optical density was measured at 270 nm continuously at 
intervals of 30 sec for 3 min. PON 1 activity was calculated from 
the linear part of the curve by calculating the change in OD per 
min. One unit of activity was defined as that amount of enzyme 
which produced 1 micromole of phenol per min. The molar 
extinction coefficient of phenol was 1310 M-1 cm-1 (Gan et al., 
1991). 
 
 
Inactivation of PON  
 
Heat inactivation  
 
PON activity in serum samples was also confirmed by the heat 
inactivation of PON. Selected serum, HDL or purified protein 
samples were heated at 80°C for 15 min prior to determining their  
 
 
 
 
PON activity as described above. There was no precipitation of 
protein by this treatment and the activity was essentially zero 
 
 
Electrophoresis  
 
SDS –page  
 
Polyacrylamide gel electrophoresis (10% cross linking) was carried 
out for purified human serum paraoxonase as described by Davis 
(1964) using an alkaline buffer. (Tris-glycine buffer pH 8.8) The 
electrophoresis was performed at constant voltage for 2 - 4 h. The 
gels were stained using coomassi brilliant blue dye.  
 
 
Silver staining  
 
Silver staining was carried out essentially by the method of Switzer 
et al. (1980). Protein detection by silver staining depends on the 
binding of silver ions to the amino acid side chains, the sulphydryl 
and carboxyl groups of proteins followed by reduction to free 
metallic silver. As a result, the image of protein distribution within 
the gel is based on the difference in oxidation-reduction potential 
between the gel’s area occupied by proteins and the free adjacent 
sites. It is sensitive enough to detect nanogram level of contamina-
ting proteins if any.  
 
 
Regeneration of cibacron blue gel 
 
This is the most important and necessary step employed in the 
purification of PON from human serum sample. Initially the cibacron 
blue gel was washed with 3 M NaCl to remove any protein which 
was bound to cibacron blue gel. The gel was then washed with 
excess of water to remove chloride ions. This facilitated rapid puri-
fication and higher yield. The gels could be regenerated to maxi-
mum of 4 times. 
 
 
RESULTS  
 
The total protein concentration in the partially purified 
paraoxonase (Deoxycholate fraction) was 0.7 g/l with a 
specific activity of 1.4 mU/mg and total protein concen-
tration of purified paraoxonase was 0.023 g/l with a speci-
fic activity of 4.6 mU/mg. 
The elution profile of PON activity from cibacron blue 
affinity column is shown in Figure 1. Protein was eluted in 
5 protein peaks while the enzyme activity was eluted in 
only 2 peaks namely peak 2 and 3. The protein elution 
and enzyme elution did not overlap. The elution of PON 
activity from sapahadex G-50 column is shown in Figure 
2. The protein and enzyme activity elution overlapped. 
However a single symmetrical peak was not obtained. 
The electrophoretic pattern of the purified protein is 
shown in Figure 3A and B, a single band was obtained 
both in coomassi blue staining as well as silver staining.  
The scheme of purification of PON is summarized in 
Table 1. The final product was 27.7 fold purified com-
pared with pooled serum.  
 
 
DISCUSSION  
 
Since PON and HDL are tightly associated, during  purifi-
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Figure 1. Elution of PON activity from cibacron blue sepharose column by deoxy cholate 
cibacron blue sepharose (30 ml) was packed in a column (40 × 2 cm). Pooled human 
serum was diluted with load buffer and passed through the column. Column was washed 
with 4 M NaCl followed by elution with 0.1% deoxycholate solution. Protein in the eluted 
fraction was monitored at 280 nm. The activity was monitored by measuring aryl esterase 
activity. 
 
 
 
G-50  Fraction 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1 6 11 16 21 26
Fraction Number 
O
D 
@
 
28
0 
n
m
 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
PO
N 
ac
tiv
ity
 
( U
/ 0
.
1 
m
l 
)
OD @ 280 nm 
PON activity 
 
 
Figure 2. Elution profile of PON activity from sephadex G-50 column.Fraction having 
PON activity from cibacron blue column was pooled, concentrated and dialyzed 
against water. It was loaded on a column of sephadex G-50 (50 × 2 cm) 
preequilibrated and eluted with 0.5 M NaCl. Protein in the fractions (1 ml) was 
monitored at 280 nm and the activity was monitored by measuring the aryl esterase 
activity. 
 
 
 
purification of PON, it is generally associated with APO-
A1 and separating the 2 has been very difficult. APO-A1 
is a major protein component of high density lipoprotein 
(HDL) with molecular weight of 29 KDa. APO-AI pro-
motes cholesterol efflux from tissues to the liver for 
excretion and also play a major role in preventing accu-
mulation of cholesterol loaded macrophage with in the 
arterial wall as a foam cells. APO-AI is also a cofactor for 
LCAT factors that up regulate PON1 gene also up 
regulate Apo A1 gene (Hirz and Scanu, 1970). Apo A1 up 
regulation is associated with increase in HDL. (Hesler et 
al., 1988) PON 1 is also shown to strongly associate with 
apo A1 (Mackness, 1998) in HDL. This may be 
responsible for keeping PON completely associated with  
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Table 1. Scheme for purification of PON activity. 
 
Fraction Amount of Protein Specific activity (mU/mg) 
Serum 8.750 g/l 0.166 
HghhDe   oxycholate fraction (Dialyzed)                  0.7 g/l 1.4 
G- 50 fraction 0.023 g/l 4.6 
 
 
 
                   
         Figure 3a                                                                    Figure 3b  
 
 
Figure 3. Electrophoresis –SDS PAGE  
 (a) Coomassi staining (10%). 
 (b) Silver staining. 
 
 
 
HDL in the serum (Jenne et al., 1991). Separation of 
APO AI and PON may result in the loss of PON activity. 
In this study the total recovery of enzyme activity was 
only 7.3% of the initial activity. It is possible that the entire 
PON enzyme may not be associated with HDL. It is also 
possible that there may be pool of modified HDL which 
does not bind to the affinity matrix. During purification the 
loss of activity of PON may also be because of the loss of 
its natural lipid environment. It is also possible that the 
PON may not be as active in the dissociated form as it in 
the native form. This is consistent with the report that 
purified PON loses its activity rapidly (Aviram et al., 
1998). However our data show that the specific activity at 
the cibacron blue step is about 8 fold higher than that of 
the serum and in the sephadex gel filtration step it is fur-
ther improved 3 fold.  
Since aryl esterase was used to monitor the elution of 
PON,  the  enzyme  assayed  as PON may not be entirely 
PON, but may have represented other esterases also. 
For example, serum cholinesterase also shows 
arylesterase activity but their contribution to the total 
activity would be less than 5%. However, this esterase 
would not be active in high salt solution where only PON 
is active. We have also shown that the non specific 
esterase hydrolyzes phenyl acetate at high pH and the 
activity of non specific esterase at pH 8 is negligible. 
Hence the phenyl acetate hydrolyzing PON activity alone 
may be seen in the deoxycholate fraction. 
It is interesting that a single band was obtained even 
when the sephadex G-50 fraction did not show a symme-
trical peak. It is possible that some of the PON may still 
attach to lipid non-covalently in the gel filtration step, 
since PON is known to bind to lipid it may still be asso-
ciated in the fractionation. However in SDS – page the 
lipid would be dissociated giving only single band. 
It is interesting to note that the PON activity recovered 
from the purification steps is low. Since Indians have a 
high prevalence for cardiovascular diseases (Goyal and 
Yusuf, 2006; Singh et al., 2007). it is tempting to spe-
culate that the active HDL which would be cardio 
protective is low among Indians while the non functional 
HDL even though high, may not contain PON or may 
contain some inactive form  of PON. 
 
 
Conclusion 
 
We report a simple and rapid method of purification of 
PON from human serum in sufficient quantity in very 
short time and also we show the regeneration of the 
affinity gel for reuse. 
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